nodes	percent_of_prediction	percent_of_DWPC	metapath
Vidarabine—ADK—Pitavastatin—Rosuvastatin—atherosclerosis	0.0358	1	CbGdCrCtD
Vidarabine—DPP4—blood vessel—atherosclerosis	0.0154	0.158	CbGeAlD
Vidarabine—Hyperventilation—Niacin—atherosclerosis	0.0117	0.0223	CcSEcCtD
Vidarabine—Burning sensation—Niacin—atherosclerosis	0.0116	0.0221	CcSEcCtD
Vidarabine—Adenosine triphosphate—ABCG1—atherosclerosis	0.0114	0.266	CrCbGaD
Vidarabine—Tingling sensation—Niacin—atherosclerosis	0.01	0.0191	CcSEcCtD
Vidarabine—ADA—connective tissue—atherosclerosis	0.00999	0.103	CbGeAlD
Vidarabine—Numbness—Pravastatin—atherosclerosis	0.00957	0.0182	CcSEcCtD
Vidarabine—Sensory loss—Pravastatin—atherosclerosis	0.00916	0.0174	CcSEcCtD
Vidarabine—ADA—cardiovascular system—atherosclerosis	0.0087	0.0892	CbGeAlD
Vidarabine—Adenosine triphosphate—HSPA1B—atherosclerosis	0.00863	0.202	CrCbGaD
Vidarabine—DPP4—connective tissue—atherosclerosis	0.00792	0.0812	CbGeAlD
Vidarabine—ADORA2A—cardiovascular system—atherosclerosis	0.00791	0.0812	CbGeAlD
Vidarabine—ADA—adipose tissue—atherosclerosis	0.00767	0.0787	CbGeAlD
Vidarabine—Glucosamine—IFNG—atherosclerosis	0.00754	0.176	CrCbGaD
Vidarabine—ADK—cardiovascular system—atherosclerosis	0.00711	0.0729	CbGeAlD
Vidarabine—DPP4—cardiovascular system—atherosclerosis	0.00689	0.0707	CbGeAlD
Vidarabine—Atrial fibrillation—Simvastatin—atherosclerosis	0.00672	0.0128	CcSEcCtD
Vidarabine—ADK—adipose tissue—atherosclerosis	0.00627	0.0643	CbGeAlD
Vidarabine—Atrial fibrillation—Niacin—atherosclerosis	0.00617	0.0117	CcSEcCtD
Vidarabine—DPP4—adipose tissue—atherosclerosis	0.00607	0.0623	CbGeAlD
Vidarabine—Affect lability—Pravastatin—atherosclerosis	0.00567	0.0108	CcSEcCtD
Vidarabine—Abdominal discomfort—Lovastatin—atherosclerosis	0.00564	0.0107	CcSEcCtD
Vidarabine—Mood swings—Pravastatin—atherosclerosis	0.00546	0.0104	CcSEcCtD
Vidarabine—Abdominal discomfort—Simvastatin—atherosclerosis	0.00528	0.01	CcSEcCtD
Vidarabine—Arrhythmia—Rosuvastatin—atherosclerosis	0.00497	0.00945	CcSEcCtD
Vidarabine—ADORA2A—liver—atherosclerosis	0.00489	0.0502	CbGeAlD
Vidarabine—Glucosamine—MMP9—atherosclerosis	0.00481	0.112	CrCbGaD
Vidarabine—Angioedema—Rosuvastatin—atherosclerosis	0.00442	0.00841	CcSEcCtD
Vidarabine—ADK—liver—atherosclerosis	0.00439	0.0451	CbGeAlD
Vidarabine—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00438	0.00833	CcSEcCtD
Vidarabine—Flushing—Lovastatin—atherosclerosis	0.00437	0.00832	CcSEcCtD
Vidarabine—Myocardial infarction—Pravastatin—atherosclerosis	0.00435	0.00828	CcSEcCtD
Vidarabine—Sweating—Niacin—atherosclerosis	0.00432	0.00822	CcSEcCtD
Vidarabine—Flushing—Ezetimibe—atherosclerosis	0.00429	0.00816	CcSEcCtD
Vidarabine—DPP4—liver—atherosclerosis	0.00426	0.0437	CbGeAlD
Vidarabine—Cough—Rosuvastatin—atherosclerosis	0.00422	0.00804	CcSEcCtD
Vidarabine—Adenosine triphosphate—ABCA1—atherosclerosis	0.00421	0.0984	CrCbGaD
Vidarabine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00417	0.00792	CcSEcCtD
Vidarabine—Flushing—Simvastatin—atherosclerosis	0.00409	0.00778	CcSEcCtD
Vidarabine—Hypoaesthesia—Niacin—atherosclerosis	0.00403	0.00766	CcSEcCtD
Vidarabine—Dysgeusia—Lovastatin—atherosclerosis	0.00402	0.00764	CcSEcCtD
Vidarabine—Back pain—Lovastatin—atherosclerosis	0.00397	0.00755	CcSEcCtD
Vidarabine—Hypoaesthesia—Pravastatin—atherosclerosis	0.00396	0.00754	CcSEcCtD
Vidarabine—Back pain—Ezetimibe—atherosclerosis	0.00389	0.0074	CcSEcCtD
Vidarabine—Vision blurred—Lovastatin—atherosclerosis	0.00387	0.00736	CcSEcCtD
Vidarabine—Tremor—Lovastatin—atherosclerosis	0.00384	0.00731	CcSEcCtD
Vidarabine—Tinnitus—Niacin—atherosclerosis	0.00377	0.00718	CcSEcCtD
Vidarabine—Dysgeusia—Simvastatin—atherosclerosis	0.00376	0.00715	CcSEcCtD
Vidarabine—Flushing—Niacin—atherosclerosis	0.00376	0.00715	CcSEcCtD
Vidarabine—Angioedema—Lovastatin—atherosclerosis	0.00375	0.00713	CcSEcCtD
Vidarabine—Tinnitus—Pravastatin—atherosclerosis	0.00372	0.00707	CcSEcCtD
Vidarabine—Cardiac disorder—Pravastatin—atherosclerosis	0.0037	0.00704	CcSEcCtD
Vidarabine—Flushing—Pravastatin—atherosclerosis	0.0037	0.00704	CcSEcCtD
Vidarabine—Angioedema—Ezetimibe—atherosclerosis	0.00368	0.00699	CcSEcCtD
Vidarabine—Vision blurred—Simvastatin—atherosclerosis	0.00362	0.00688	CcSEcCtD
Vidarabine—Arrhythmia—Niacin—atherosclerosis	0.00362	0.00688	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.0036	0.00685	CcSEcCtD
Vidarabine—Tremor—Simvastatin—atherosclerosis	0.00359	0.00684	CcSEcCtD
Vidarabine—Arrhythmia—Pravastatin—atherosclerosis	0.00356	0.00677	CcSEcCtD
Vidarabine—Palpitations—Ezetimibe—atherosclerosis	0.00356	0.00676	CcSEcCtD
Vidarabine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00355	0.00675	CcSEcCtD
Vidarabine—Cough—Ezetimibe—atherosclerosis	0.00351	0.00668	CcSEcCtD
Vidarabine—Angioedema—Simvastatin—atherosclerosis	0.00351	0.00667	CcSEcCtD
Vidarabine—Chest pain—Lovastatin—atherosclerosis	0.00349	0.00664	CcSEcCtD
Vidarabine—Anxiety—Lovastatin—atherosclerosis	0.00348	0.00662	CcSEcCtD
Vidarabine—Hypertension—Ezetimibe—atherosclerosis	0.00347	0.00661	CcSEcCtD
Vidarabine—Tension—Niacin—atherosclerosis	0.00346	0.00658	CcSEcCtD
Vidarabine—Discomfort—Lovastatin—atherosclerosis	0.00345	0.00656	CcSEcCtD
Vidarabine—Chest pain—Ezetimibe—atherosclerosis	0.00343	0.00652	CcSEcCtD
Vidarabine—Nervousness—Niacin—atherosclerosis	0.00342	0.00651	CcSEcCtD
Vidarabine—Dry mouth—Lovastatin—atherosclerosis	0.00342	0.0065	CcSEcCtD
Vidarabine—Tension—Pravastatin—atherosclerosis	0.0034	0.00648	CcSEcCtD
Vidarabine—Dysgeusia—Pravastatin—atherosclerosis	0.0034	0.00646	CcSEcCtD
Vidarabine—Discomfort—Ezetimibe—atherosclerosis	0.00338	0.00644	CcSEcCtD
Vidarabine—Pain—Rosuvastatin—atherosclerosis	0.00338	0.00643	CcSEcCtD
Vidarabine—Nervousness—Pravastatin—atherosclerosis	0.00337	0.00641	CcSEcCtD
Vidarabine—Dry mouth—Ezetimibe—atherosclerosis	0.00335	0.00637	CcSEcCtD
Vidarabine—Anaphylactic shock—Lovastatin—atherosclerosis	0.00335	0.00637	CcSEcCtD
Vidarabine—Vision blurred—Niacin—atherosclerosis	0.00332	0.00632	CcSEcCtD
Vidarabine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00328	0.00625	CcSEcCtD
Vidarabine—Vision blurred—Pravastatin—atherosclerosis	0.00327	0.00622	CcSEcCtD
Vidarabine—Chest pain—Simvastatin—atherosclerosis	0.00327	0.00621	CcSEcCtD
Vidarabine—Anxiety—Simvastatin—atherosclerosis	0.00326	0.00619	CcSEcCtD
Vidarabine—Tremor—Pravastatin—atherosclerosis	0.00325	0.00618	CcSEcCtD
Vidarabine—Discomfort—Simvastatin—atherosclerosis	0.00323	0.00614	CcSEcCtD
Vidarabine—Angioedema—Niacin—atherosclerosis	0.00322	0.00612	CcSEcCtD
Vidarabine—Angioedema—Pravastatin—atherosclerosis	0.00317	0.00603	CcSEcCtD
Vidarabine—Syncope—Niacin—atherosclerosis	0.00316	0.00601	CcSEcCtD
Vidarabine—Glucosamine—TNF—atherosclerosis	0.00316	0.0738	CrCbGaD
Vidarabine—Urticaria—Rosuvastatin—atherosclerosis	0.00314	0.00597	CcSEcCtD
Vidarabine—Anaphylactic shock—Simvastatin—atherosclerosis	0.00313	0.00596	CcSEcCtD
Vidarabine—Palpitations—Niacin—atherosclerosis	0.00311	0.00592	CcSEcCtD
Vidarabine—Loss of consciousness—Niacin—atherosclerosis	0.0031	0.00589	CcSEcCtD
Vidarabine—Adenosine triphosphate—AKT1—atherosclerosis	0.00309	0.0722	CrCbGaD
Vidarabine—Cough—Niacin—atherosclerosis	0.00307	0.00585	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00305	0.0058	CcSEcCtD
Vidarabine—Cough—Pravastatin—atherosclerosis	0.00303	0.00576	CcSEcCtD
Vidarabine—Paraesthesia—Lovastatin—atherosclerosis	0.00301	0.00572	CcSEcCtD
Vidarabine—Hypertension—Pravastatin—atherosclerosis	0.00299	0.0057	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00299	0.00569	CcSEcCtD
Vidarabine—Dyspnoea—Lovastatin—atherosclerosis	0.00298	0.00568	CcSEcCtD
Vidarabine—Chest pain—Pravastatin—atherosclerosis	0.00295	0.00562	CcSEcCtD
Vidarabine—Paraesthesia—Ezetimibe—atherosclerosis	0.00295	0.00561	CcSEcCtD
Vidarabine—Anxiety—Pravastatin—atherosclerosis	0.00294	0.0056	CcSEcCtD
Vidarabine—Dry mouth—Niacin—atherosclerosis	0.00293	0.00558	CcSEcCtD
Vidarabine—Dyspnoea—Ezetimibe—atherosclerosis	0.00293	0.00557	CcSEcCtD
Vidarabine—Discomfort—Pravastatin—atherosclerosis	0.00292	0.00555	CcSEcCtD
Vidarabine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00291	0.00554	CcSEcCtD
Vidarabine—Anaphylactic shock—Niacin—atherosclerosis	0.00288	0.00547	CcSEcCtD
Vidarabine—Pain—Lovastatin—atherosclerosis	0.00286	0.00545	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00285	0.00543	CcSEcCtD
Vidarabine—Asthenia—Rosuvastatin—atherosclerosis	0.00283	0.00539	CcSEcCtD
Vidarabine—Anaphylactic shock—Pravastatin—atherosclerosis	0.00283	0.00539	CcSEcCtD
Vidarabine—Shock—Niacin—atherosclerosis	0.00283	0.00538	CcSEcCtD
Vidarabine—Paraesthesia—Simvastatin—atherosclerosis	0.00281	0.00535	CcSEcCtD
Vidarabine—Pain—Ezetimibe—atherosclerosis	0.00281	0.00534	CcSEcCtD
Vidarabine—Tachycardia—Niacin—atherosclerosis	0.00281	0.00534	CcSEcCtD
Vidarabine—Dyspnoea—Simvastatin—atherosclerosis	0.00279	0.00531	CcSEcCtD
Vidarabine—Hyperhidrosis—Niacin—atherosclerosis	0.00278	0.00529	CcSEcCtD
Vidarabine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00274	0.00521	CcSEcCtD
Vidarabine—Hypotension—Niacin—atherosclerosis	0.00269	0.00511	CcSEcCtD
Vidarabine—Pain—Simvastatin—atherosclerosis	0.00268	0.00509	CcSEcCtD
Vidarabine—Urticaria—Lovastatin—atherosclerosis	0.00266	0.00506	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00262	0.00498	CcSEcCtD
Vidarabine—Dizziness—Rosuvastatin—atherosclerosis	0.00261	0.00497	CcSEcCtD
Vidarabine—Urticaria—Ezetimibe—atherosclerosis	0.00261	0.00496	CcSEcCtD
Vidarabine—Paraesthesia—Niacin—atherosclerosis	0.00258	0.00491	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00258	0.00491	CcSEcCtD
Vidarabine—Dyspnoea—Niacin—atherosclerosis	0.00256	0.00488	CcSEcCtD
Vidarabine—Somnolence—Niacin—atherosclerosis	0.00256	0.00486	CcSEcCtD
Vidarabine—Paraesthesia—Pravastatin—atherosclerosis	0.00254	0.00484	CcSEcCtD
Vidarabine—Dyspnoea—Pravastatin—atherosclerosis	0.00252	0.0048	CcSEcCtD
Vidarabine—Rash—Rosuvastatin—atherosclerosis	0.00249	0.00474	CcSEcCtD
Vidarabine—Dermatitis—Rosuvastatin—atherosclerosis	0.00249	0.00473	CcSEcCtD
Vidarabine—Urticaria—Simvastatin—atherosclerosis	0.00249	0.00473	CcSEcCtD
Vidarabine—Headache—Rosuvastatin—atherosclerosis	0.00247	0.00471	CcSEcCtD
Vidarabine—Hypersensitivity—Lovastatin—atherosclerosis	0.00247	0.00469	CcSEcCtD
Vidarabine—Pain—Niacin—atherosclerosis	0.00246	0.00468	CcSEcCtD
Vidarabine—Pain—Pravastatin—atherosclerosis	0.00242	0.00461	CcSEcCtD
Vidarabine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00242	0.0046	CcSEcCtD
Vidarabine—Asthenia—Lovastatin—atherosclerosis	0.0024	0.00457	CcSEcCtD
Vidarabine—Asthenia—Ezetimibe—atherosclerosis	0.00236	0.00448	CcSEcCtD
Vidarabine—Nausea—Rosuvastatin—atherosclerosis	0.00235	0.00446	CcSEcCtD
Vidarabine—Hypersensitivity—Simvastatin—atherosclerosis	0.00231	0.00439	CcSEcCtD
Vidarabine—Urticaria—Niacin—atherosclerosis	0.00228	0.00435	CcSEcCtD
Vidarabine—Urticaria—Pravastatin—atherosclerosis	0.00225	0.00428	CcSEcCtD
Vidarabine—Asthenia—Simvastatin—atherosclerosis	0.00225	0.00427	CcSEcCtD
Vidarabine—Dizziness—Lovastatin—atherosclerosis	0.00221	0.00421	CcSEcCtD
Vidarabine—Dizziness—Ezetimibe—atherosclerosis	0.00217	0.00413	CcSEcCtD
Vidarabine—Vomiting—Lovastatin—atherosclerosis	0.00213	0.00405	CcSEcCtD
Vidarabine—Hypersensitivity—Niacin—atherosclerosis	0.00212	0.00403	CcSEcCtD
Vidarabine—Rash—Lovastatin—atherosclerosis	0.00211	0.00402	CcSEcCtD
Vidarabine—Dermatitis—Lovastatin—atherosclerosis	0.00211	0.00401	CcSEcCtD
Vidarabine—Headache—Lovastatin—atherosclerosis	0.0021	0.00399	CcSEcCtD
Vidarabine—Vomiting—Ezetimibe—atherosclerosis	0.00209	0.00397	CcSEcCtD
Vidarabine—Hypersensitivity—Pravastatin—atherosclerosis	0.00209	0.00397	CcSEcCtD
Vidarabine—Dizziness—Simvastatin—atherosclerosis	0.00207	0.00394	CcSEcCtD
Vidarabine—Rash—Ezetimibe—atherosclerosis	0.00207	0.00394	CcSEcCtD
Vidarabine—Dermatitis—Ezetimibe—atherosclerosis	0.00207	0.00394	CcSEcCtD
Vidarabine—Asthenia—Niacin—atherosclerosis	0.00206	0.00392	CcSEcCtD
Vidarabine—Headache—Ezetimibe—atherosclerosis	0.00206	0.00391	CcSEcCtD
Vidarabine—Asthenia—Pravastatin—atherosclerosis	0.00203	0.00386	CcSEcCtD
Vidarabine—Vomiting—Simvastatin—atherosclerosis	0.00199	0.00379	CcSEcCtD
Vidarabine—Nausea—Lovastatin—atherosclerosis	0.00199	0.00378	CcSEcCtD
Vidarabine—Rash—Simvastatin—atherosclerosis	0.00197	0.00376	CcSEcCtD
Vidarabine—Dermatitis—Simvastatin—atherosclerosis	0.00197	0.00375	CcSEcCtD
Vidarabine—Headache—Simvastatin—atherosclerosis	0.00196	0.00373	CcSEcCtD
Vidarabine—Nausea—Ezetimibe—atherosclerosis	0.00195	0.00371	CcSEcCtD
Vidarabine—Dizziness—Niacin—atherosclerosis	0.0019	0.00362	CcSEcCtD
Vidarabine—Dizziness—Pravastatin—atherosclerosis	0.00187	0.00356	CcSEcCtD
Vidarabine—Nausea—Simvastatin—atherosclerosis	0.00186	0.00354	CcSEcCtD
Vidarabine—Vomiting—Niacin—atherosclerosis	0.00183	0.00348	CcSEcCtD
Vidarabine—Rash—Niacin—atherosclerosis	0.00181	0.00345	CcSEcCtD
Vidarabine—Dermatitis—Niacin—atherosclerosis	0.00181	0.00345	CcSEcCtD
Vidarabine—Headache—Niacin—atherosclerosis	0.0018	0.00343	CcSEcCtD
Vidarabine—Vomiting—Pravastatin—atherosclerosis	0.0018	0.00342	CcSEcCtD
Vidarabine—Rash—Pravastatin—atherosclerosis	0.00178	0.0034	CcSEcCtD
Vidarabine—Dermatitis—Pravastatin—atherosclerosis	0.00178	0.00339	CcSEcCtD
Vidarabine—Headache—Pravastatin—atherosclerosis	0.00177	0.00337	CcSEcCtD
Vidarabine—Nausea—Niacin—atherosclerosis	0.00171	0.00325	CcSEcCtD
Vidarabine—Nausea—Pravastatin—atherosclerosis	0.00168	0.0032	CcSEcCtD
Vidarabine—ADA—Metabolism—ABCG8—atherosclerosis	0.00101	0.00339	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—SERPINE1—atherosclerosis	0.000997	0.00334	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CYP27A1—atherosclerosis	0.000986	0.0033	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL3—atherosclerosis	0.000966	0.00324	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—UTS2—atherosclerosis	0.00096	0.00322	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—GHRL—atherosclerosis	0.000952	0.00319	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PLA2G2A—atherosclerosis	0.000934	0.00313	CbGpPWpGaD
Vidarabine—ADK—Metabolism—APOA2—atherosclerosis	0.000934	0.00313	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ALOX15—atherosclerosis	0.000934	0.00313	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ALOX5AP—atherosclerosis	0.000934	0.00313	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—SIRT1—atherosclerosis	0.000925	0.0031	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ABCG5—atherosclerosis	0.000923	0.00309	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—ACE—atherosclerosis	0.000922	0.00309	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CX3CR1—atherosclerosis	0.00092	0.00309	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CASR—atherosclerosis	0.00092	0.00309	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CX3CL1—atherosclerosis	0.000903	0.00303	CbGpPWpGaD
Vidarabine—ADK—Metabolism—LPA—atherosclerosis	0.000891	0.00299	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.000874	0.00293	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.000874	0.00293	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	0.000867	0.00291	CbGpPWpGaD
Vidarabine—ADK—Metabolism—BGN—atherosclerosis	0.000863	0.00289	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CNR2—atherosclerosis	0.000856	0.00287	CbGpPWpGaD
Vidarabine—ADK—Metabolism—APOA5—atherosclerosis	0.000855	0.00287	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.000851	0.00285	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—PRKCG—atherosclerosis	0.000847	0.00284	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—HRH1—atherosclerosis	0.000842	0.00282	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PRKCG—atherosclerosis	0.00083	0.00278	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—PLAUR—atherosclerosis	0.000829	0.00278	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PLA2G1B—atherosclerosis	0.000823	0.00276	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—PLG—atherosclerosis	0.00081	0.00272	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ABCG1—atherosclerosis	0.0008	0.00268	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ALOX5—atherosclerosis	0.000795	0.00266	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—PPARA—atherosclerosis	0.000769	0.00258	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—HRH1—atherosclerosis	0.000764	0.00256	CbGpPWpGaD
Vidarabine—ADA—Metabolism—FABP4—atherosclerosis	0.000752	0.00252	CbGpPWpGaD
Vidarabine—ADA—Metabolism—LCAT—atherosclerosis	0.000752	0.00252	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PDGFB—atherosclerosis	0.000748	0.00251	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.000747	0.00251	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—MAPK8—atherosclerosis	0.000743	0.00249	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.000743	0.00249	CbGpPWpGaD
Vidarabine—ADA—Metabolism—APOA4—atherosclerosis	0.000738	0.00247	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—IGF2—atherosclerosis	0.000737	0.00247	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CCL3—atherosclerosis	0.000736	0.00247	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—LEP—atherosclerosis	0.00073	0.00245	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP7A1—atherosclerosis	0.000725	0.00243	CbGpPWpGaD
Vidarabine—ADK—Metabolism—NAMPT—atherosclerosis	0.000713	0.00239	CbGpPWpGaD
Vidarabine—ADK—Metabolism—LIPC—atherosclerosis	0.000708	0.00237	CbGpPWpGaD
Vidarabine—ADK—Metabolism—APOC3—atherosclerosis	0.000704	0.00236	CbGpPWpGaD
Vidarabine—ADK—Metabolism—LDLR—atherosclerosis	0.000699	0.00235	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CETP—atherosclerosis	0.000683	0.00229	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—NOS2—atherosclerosis	0.00068	0.00228	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP27A1—atherosclerosis	0.00067	0.00225	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CCR2—atherosclerosis	0.000665	0.00223	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—EDNRA—atherosclerosis	0.000665	0.00223	CbGpPWpGaD
Vidarabine—ADK—Metabolism—SCARB1—atherosclerosis	0.000654	0.00219	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—GHRL—atherosclerosis	0.000648	0.00217	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PRKCG—atherosclerosis	0.000639	0.00214	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—PPARG—atherosclerosis	0.000636	0.00213	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ALOX5AP—atherosclerosis	0.000635	0.00213	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PLA2G2A—atherosclerosis	0.000635	0.00213	CbGpPWpGaD
Vidarabine—ADA—Metabolism—APOA2—atherosclerosis	0.000635	0.00213	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ALOX15—atherosclerosis	0.000635	0.00213	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.00063	0.00211	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ABCG5—atherosclerosis	0.000627	0.0021	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.000625	0.0021	CbGpPWpGaD
Vidarabine—ADK—Metabolism—HMGCR—atherosclerosis	0.000618	0.00207	CbGpPWpGaD
Vidarabine—ADA—Metabolism—LPA—atherosclerosis	0.000606	0.00203	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—MMP1—atherosclerosis	0.000592	0.00199	CbGpPWpGaD
Vidarabine—ADA—Metabolism—BGN—atherosclerosis	0.000587	0.00197	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—AGT—atherosclerosis	0.000585	0.00196	CbGpPWpGaD
Vidarabine—ADA—Metabolism—APOA5—atherosclerosis	0.000581	0.00195	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PDGFB—atherosclerosis	0.000576	0.00193	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—LEP—atherosclerosis	0.000573	0.00192	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—SERPINE1—atherosclerosis	0.000573	0.00192	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—KNG1—atherosclerosis	0.000569	0.00191	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—AGTR1—atherosclerosis	0.000566	0.0019	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PLA2G1B—atherosclerosis	0.000559	0.00187	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCL4—atherosclerosis	0.000553	0.00185	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ABCA1—atherosclerosis	0.000551	0.00185	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—UTS2—atherosclerosis	0.000542	0.00182	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—F2—atherosclerosis	0.00054	0.00181	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ALOX5—atherosclerosis	0.00054	0.00181	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.000523	0.00175	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CASR—atherosclerosis	0.00052	0.00174	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—UTS2—atherosclerosis	0.000493	0.00165	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—INS—atherosclerosis	0.000489	0.00164	CbGpPWpGaD
Vidarabine—ADA—Metabolism—NAMPT—atherosclerosis	0.000484	0.00162	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CNR2—atherosclerosis	0.000483	0.00162	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.000483	0.00162	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—CCL2—atherosclerosis	0.000482	0.00161	CbGpPWpGaD
Vidarabine—ADA—Metabolism—LIPC—atherosclerosis	0.000481	0.00161	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—EDN1—atherosclerosis	0.00048	0.00161	CbGpPWpGaD
Vidarabine—ADA—Metabolism—APOC3—atherosclerosis	0.000478	0.0016	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CCL5—atherosclerosis	0.000476	0.0016	CbGpPWpGaD
Vidarabine—ADA—Metabolism—LDLR—atherosclerosis	0.000475	0.00159	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—IL6—atherosclerosis	0.000474	0.00159	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—IGF1—atherosclerosis	0.000473	0.00159	CbGpPWpGaD
Vidarabine—ADK—Metabolism—HMOX1—atherosclerosis	0.000472	0.00158	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CX3CR1—atherosclerosis	0.000472	0.00158	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CASR—atherosclerosis	0.000472	0.00158	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CETP—atherosclerosis	0.000464	0.00156	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CX3CL1—atherosclerosis	0.000463	0.00155	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—MMP2—atherosclerosis	0.000458	0.00154	CbGpPWpGaD
Vidarabine—ADK—Metabolism—APOB—atherosclerosis	0.000453	0.00152	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HRH1—atherosclerosis	0.000452	0.00151	CbGpPWpGaD
Vidarabine—ADA—Metabolism—SCARB1—atherosclerosis	0.000445	0.00149	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GSTM1—atherosclerosis	0.00044	0.00148	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CNR2—atherosclerosis	0.000439	0.00147	CbGpPWpGaD
Vidarabine—ADK—Metabolism—LPL—atherosclerosis	0.000432	0.00145	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000431	0.00144	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—MAPK8—atherosclerosis	0.000427	0.00143	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GPX1—atherosclerosis	0.000422	0.00141	CbGpPWpGaD
Vidarabine—ADA—Metabolism—HMGCR—atherosclerosis	0.00042	0.00141	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CD36—atherosclerosis	0.000411	0.00138	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—AGT—atherosclerosis	0.000398	0.00133	CbGpPWpGaD
Vidarabine—ADK—Metabolism—MTHFR—atherosclerosis	0.000389	0.0013	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—atherosclerosis	0.000383	0.00128	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PPARA—atherosclerosis	0.000382	0.00128	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—CXCL8—atherosclerosis	0.000381	0.00128	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCL3—atherosclerosis	0.000378	0.00127	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—EDNRA—atherosclerosis	0.000376	0.00126	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CCR2—atherosclerosis	0.000376	0.00126	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ABCA1—atherosclerosis	0.000374	0.00126	CbGpPWpGaD
Vidarabine—ADK—Metabolism—AGT—atherosclerosis	0.00037	0.00124	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—F2—atherosclerosis	0.000368	0.00123	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GHRL—atherosclerosis	0.000366	0.00123	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MAPK3—atherosclerosis	0.000365	0.00123	CbGpPWpGaD
Vidarabine—ADK—Metabolism—APOE—atherosclerosis	0.000362	0.00121	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CAV1—atherosclerosis	0.000359	0.0012	CbGpPWpGaD
Vidarabine—ADK—Metabolism—APOA1—atherosclerosis	0.000358	0.0012	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APOA4—atherosclerosis	0.000354	0.00119	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—EDNRA—atherosclerosis	0.000341	0.00114	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCR2—atherosclerosis	0.000341	0.00114	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.00034	0.00114	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GHRL—atherosclerosis	0.000333	0.00112	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CCL2—atherosclerosis	0.000328	0.0011	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—NFKB1—atherosclerosis	0.000327	0.0011	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PIK3CG—atherosclerosis	0.000327	0.0011	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL4—atherosclerosis	0.000326	0.00109	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—MAPK8—atherosclerosis	0.000322	0.00108	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—KNG1—atherosclerosis	0.000322	0.00108	CbGpPWpGaD
Vidarabine—ADA—Metabolism—HMOX1—atherosclerosis	0.000321	0.00108	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AGTR1—atherosclerosis	0.00032	0.00107	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PPARG—atherosclerosis	0.000316	0.00106	CbGpPWpGaD
Vidarabine—ADK—Metabolism—INS—atherosclerosis	0.000309	0.00104	CbGpPWpGaD
Vidarabine—ADA—Metabolism—APOB—atherosclerosis	0.000308	0.00103	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APOA2—atherosclerosis	0.000305	0.00102	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GSTM1—atherosclerosis	0.000299	0.001	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—STAT3—atherosclerosis	0.000294	0.000987	CbGpPWpGaD
Vidarabine—ADA—Metabolism—LPL—atherosclerosis	0.000294	0.000985	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—KNG1—atherosclerosis	0.000292	0.000979	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—UTS2—atherosclerosis	0.000291	0.000976	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AGTR1—atherosclerosis	0.00029	0.000973	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GPX1—atherosclerosis	0.000287	0.000961	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ALB—atherosclerosis	0.000284	0.000951	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—MAPK3—atherosclerosis	0.000281	0.000942	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CD36—atherosclerosis	0.000279	0.000936	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CX3CR1—atherosclerosis	0.000279	0.000935	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CASR—atherosclerosis	0.000279	0.000935	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CX3CL1—atherosclerosis	0.000274	0.000917	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—IL6—atherosclerosis	0.000273	0.000914	CbGpPWpGaD
Vidarabine—ADK—Metabolism—NOS3—atherosclerosis	0.000271	0.00091	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—EDN1—atherosclerosis	0.000271	0.000909	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CCL5—atherosclerosis	0.000269	0.000902	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—atherosclerosis	0.000267	0.000896	CbGpPWpGaD
Vidarabine—ADA—Metabolism—MTHFR—atherosclerosis	0.000264	0.000887	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PPARA—atherosclerosis	0.000259	0.00087	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CNR2—atherosclerosis	0.000259	0.00087	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CXCL8—atherosclerosis	0.000259	0.000869	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—MMP3—atherosclerosis	0.000259	0.000868	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PRKCG—atherosclerosis	0.000256	0.000857	CbGpPWpGaD
Vidarabine—ADA—Metabolism—AGT—atherosclerosis	0.000251	0.000843	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PTGS2—atherosclerosis	0.000248	0.000832	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—atherosclerosis	0.000247	0.000827	CbGpPWpGaD
Vidarabine—ADA—Metabolism—APOE—atherosclerosis	0.000246	0.000826	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—EDN1—atherosclerosis	0.000246	0.000825	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCL5—atherosclerosis	0.000244	0.000819	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CAV1—atherosclerosis	0.000244	0.000818	CbGpPWpGaD
Vidarabine—ADA—Metabolism—APOA1—atherosclerosis	0.000243	0.000816	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PRKCG—atherosclerosis	0.000232	0.000779	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—VWF—atherosclerosis	0.000231	0.000775	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APOC3—atherosclerosis	0.00023	0.00077	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—LDLR—atherosclerosis	0.000228	0.000766	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AGT—atherosclerosis	0.000225	0.000754	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL3—atherosclerosis	0.000223	0.000748	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PIK3CG—atherosclerosis	0.000222	0.000745	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PPARG—atherosclerosis	0.000214	0.000719	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NCF1—atherosclerosis	0.000214	0.000716	CbGpPWpGaD
Vidarabine—ADA—Metabolism—INS—atherosclerosis	0.00021	0.000705	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—F2—atherosclerosis	0.000208	0.000697	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—IL6—atherosclerosis	0.000206	0.000689	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AGT—atherosclerosis	0.000204	0.000685	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—EDNRA—atherosclerosis	0.000202	0.000676	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCR2—atherosclerosis	0.000202	0.000676	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CYBA—atherosclerosis	0.000201	0.000673	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000199	0.000667	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PLAT—atherosclerosis	0.000197	0.000659	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GHRL—atherosclerosis	0.000197	0.000659	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PARP1—atherosclerosis	0.000197	0.000659	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ALB—atherosclerosis	0.000193	0.000647	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—AKT1—atherosclerosis	0.00019	0.000636	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—F2—atherosclerosis	0.000189	0.000633	CbGpPWpGaD
Vidarabine—ADA—Metabolism—NOS3—atherosclerosis	0.000184	0.000618	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PIK3CG—atherosclerosis	0.000181	0.000606	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—KNG1—atherosclerosis	0.000173	0.000578	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AGTR1—atherosclerosis	0.000172	0.000575	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PTGS2—atherosclerosis	0.000169	0.000566	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCL2—atherosclerosis	0.000168	0.000564	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PLG—atherosclerosis	0.000167	0.00056	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SOCS3—atherosclerosis	0.000158	0.000531	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MMP3—atherosclerosis	0.000153	0.000513	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IGF2—atherosclerosis	0.000152	0.00051	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APOB—atherosclerosis	0.000148	0.000495	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCL8—atherosclerosis	0.000146	0.000491	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—EDN1—atherosclerosis	0.000145	0.000487	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL5—atherosclerosis	0.000144	0.000484	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—LPL—atherosclerosis	0.000141	0.000473	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRKCG—atherosclerosis	0.000137	0.00046	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SPP1—atherosclerosis	0.000134	0.000448	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCL8—atherosclerosis	0.000133	0.000446	CbGpPWpGaD
Vidarabine—ADK—Metabolism—AKT1—atherosclerosis	0.000125	0.000418	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PDGFB—atherosclerosis	0.000124	0.000415	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AGT—atherosclerosis	0.000121	0.000405	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—LEP—atherosclerosis	0.000118	0.000396	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APOE—atherosclerosis	0.000118	0.000396	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CAV1—atherosclerosis	0.000117	0.000393	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APOA1—atherosclerosis	0.000117	0.000392	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ESR1—atherosclerosis	0.000113	0.000379	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—F2—atherosclerosis	0.000112	0.000374	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PIK3CG—atherosclerosis	0.000107	0.000358	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—MAPK3—atherosclerosis	0.000102	0.000343	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—INS—atherosclerosis	0.000101	0.000339	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL2—atherosclerosis	9.94e-05	0.000333	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IGF1—atherosclerosis	9.77e-05	0.000328	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SERPINE1—atherosclerosis	9.28e-05	0.000311	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NOS3—atherosclerosis	8.86e-05	0.000297	CbGpPWpGaD
Vidarabine—ADA—Metabolism—AKT1—atherosclerosis	8.48e-05	0.000284	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCL8—atherosclerosis	7.86e-05	0.000263	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AKT1—atherosclerosis	7.59e-05	0.000255	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL6—atherosclerosis	7.47e-05	0.000251	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MMP9—atherosclerosis	7.11e-05	0.000238	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NFKB1—atherosclerosis	7.03e-05	0.000236	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MAPK8—atherosclerosis	6.91e-05	0.000232	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AKT1—atherosclerosis	6.89e-05	0.000231	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—VEGFA—atherosclerosis	6.38e-05	0.000214	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—STAT3—atherosclerosis	6.32e-05	0.000212	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MAPK3—atherosclerosis	6.04e-05	0.000202	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TGFB1—atherosclerosis	5.86e-05	0.000196	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL6—atherosclerosis	4.41e-05	0.000148	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AKT1—atherosclerosis	4.07e-05	0.000137	CbGpPWpGaD
